- BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
IDrugs : the investigational drugs journal (2004-01-20)
R Todd Reilly
PMID14730469
RESUMEN
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
MATERIALES
Referencia del producto
Marca
Descripción del producto
Mesna impurity D, European Pharmacopoeia (EP) Reference Standard